Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population. A gender-specific follow-up study

Atherosclerosis

Volumn 201, Issue 2, 2008, Pages 398-406

  Solbu, Marit D ^a,d   Kronborg, Jens ^b,d   Eriksen, Bjørn O ^a,d   Jenssen, Trond G ^c,d   Toft, Ingrid ^a,d  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b INNLANDET HOSPITAL TRUST   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Cardiovascular risk factors; Gender differences; Metabolic syndrome; Urinary albumin excretion

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN A1C;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; SYSTOLIC BLOOD PRESSURE; URINE LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; WAIST CIRCUMFERENCE;

EID: 56649093039     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.02.027     Document Type: Article

References (29)

1. Dinneen S.F., and Gerstein H.C. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 157 (1997) 1413-1418
2. Mogensen C.E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310 (1984) 356-360
3. Bigazzi R., Bianchi S., Baldari D., and Campese V.M. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 16 (1998) 1325-1333
4. Jager A., Kostense P.J., Ruhe H.G., et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 19 (1999) 617-624
5. Ljungman S., Wikstrand J., Hartford M., and Berglund G. Urinary albumin excretion-a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens 9 (1996) 770-778
6. Arnlov J., Evans J.C., Meigs J.B., et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 112 (2005) 969-975
7. Romundstad S., Holmen J., Kvenild K., Hallan H., and Ellekjaer H. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am J Kidney Dis 42 (2003) 466-473
8. Spoelstra-de Man A.M., Brouwer C.B., Stehouwer C.D., and Smulders Y.M. Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with type 2 diabetes and microalbuminuria. Diabetes Care 24 (2001) 2097-2101
9. Ibsen H., Olsen M.H., Wachtell K., et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension 45 (2005) 198-202
10. Sung K.C., Kim B.J., and Ryu S. An association of a variety of cardiovascular risk factors with low grade albuminuria in Korean men. Atherosclerosis 196 (2008) 320-326
11. Bonnet F., Marre M., Halimi J.M., et al. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. J Hypertens 24 (2006) 1165-1171
12. Brantsma A.H., Atthobari J., Bakker S.J.L., et al. What predicts progression and regression of urinary albumin excretion in the nondiabetic population?. J Am Soc Nephrol 18 (2007) 637-645
13. Bello A.K., de Zeeuw D., El Nahas M.E., et al. Impact of weight change on albuminuria in the general population. Nephrol. Dial. Transplant. 22 (2007) 1619-1627
14. De Cosmo S., Minenna A., Ludovico O., et al. Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: evidence of a sex-specific association. Diabetes Care 28 (2005) 910-915
15. Halimi J.M., Forhan A., Balkau B., et al. Is microalbuminuria an integrated risk marker for cardiovascular disease and insulin resistance in both men and women?. J Cardiovasc Risk 8 (2001) 139-146
16. Verhave J.C., Hillege H.L., Burgerhof J.G., et al. Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. J Am Soc Nephrol 14 (2003) 1330-1335
17. Levey A.S., Coresh J., Greene T., et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53 (2007) 766-772
18. Kronborg J., Johnsen S.H., Njolstad I., et al. Proinsulin:insulin and insulin:glucose ratios as predictors of carotid plaque growth: a population-based 7 year follow-up of the Tromso Study 2. Diabetologia 50 (2007) 1607-1614
19. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
20. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
21. Expert Panel on Detection EaToHBCiA. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
22. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) 10. Diabet Med 16 (1999) 442-443
23. Rowley K., O'Dea K., and Best J.D. Association of albuminuria and the metabolic syndrome. Curr Diab Rep 3 (2003) 80-86
24. Andronico G., Rome M., Lo C.A., et al. Renal plasma flow, filtration fraction and microalbuminuria in hypertensive patients: effects of chronic smoking. Nephrology (Carlton) 10 (2005) 483-486
25. Cirillo M., Senigalliesi L., Laurenzi M., et al. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. Arch Intern Med 158 (1998) 1933-1939
26. Warmoth L., Regalado M.M., Simoni J., Harrist R.B., and Wesson D.E. Cigarette smoking enhances increased urine albumin excretion as a risk factor for glomerular filtration rate decline in primary hypertension. Am J Med Sci 330 (2005) 111-119
27. Kottgen A., Russell S.D., Loehr L.R., et al. Reduced kidney function as a risk factor for incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol 18 (2007) 1307-1315
28. Kurella M., Lo J.C., and Chertow G.M. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16 (2005) 2134-2140
29. Ritz E. Cardiovascular risk factors and urinary albumin: vive la petite difference. J Am Soc Nephrol 14 (2003) 1415-1416